Viracta Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Viracta Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Viracta Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$10.2M, a 18.4% increase year-over-year.
  • Viracta Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$47.2M, a 3.07% increase year-over-year.
  • Viracta Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$50.7M, a 0.21% decline from 2022.
  • Viracta Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$50.6M, a 55.7% increase from 2021.
  • Viracta Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$114M, a 507% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$50.7M -$104K -0.21% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 -$50.6M +$63.7M +55.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 -$114M -$95.5M -507% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 -$18.8M +$4.47M +19.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 -$23.3M +$2.42M +9.42% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-24
2018 -$25.7M +$8.71M +25.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
2017 -$34.4M +$2.04M +5.6% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 -$36.5M +$2.84M +7.23% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-09
2015 -$39.3M +$5.74M +12.7% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-09
2014 -$45M -$13.3M -41.8% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-09
2013 -$31.8M +$2.83M +8.19% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 -$34.6M -$8.74M -33.8% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 -$25.9M -$4.46M -20.8% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-06
2010 -$21.4M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.